AbbVie Inc.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psori…

Drug Manufacturers - General

US, North Chicago [HQ]

Analysts
Dividend Payments
Government Awards
Insiders
Lobbying Expenses
Segment Revenues
Shareholder Structure
Supply / Portfolio
Valuation Models [Soon]

Financials

Analysts

Wall Street · Earnings · Institutional Sentiment

A comprehensive analysis section that covers unveiling insights about AbbVie Inc.'s gradings, price targets and earnings estimates. None

Earnings
Grading & Price

Reported

Past Estimate Consensus

Future Estimate Consensus

EPS Revenue EBITDA EBIT SGA

All monetary values are presented in USD ($). E stands for Estimate.

Download

FY	EPS		Revenue [mil.]		Profit [mil.]		EBITDA [mil.]		EBIT [mil.]		Expenses · SGA [mil.]
		E		E		E		E		E		E
2014	2.5800	2.830	18,790	18,546	4,128	1,593	6,561	3,246	6,002	3,096	5,352	7,185
2015	1.1100	4.289	19,960	22,859	1,774	4,939	4,197	7,865	3,763	7,217	7,724	6,115
2016	3.1500	4.824	22,859	25,701	5,144	5,835	8,373	9,926	7,687	9,204	6,387	5,746
2017	3.6500	5.560	25,638	28,002	5,953	5,229	10,573	10,199	9,584	9,426	5,855	6,156
2018	3.3100	7.960	28,216	32,817	5,309	5,331	11,093	7,867	9,919	5,973	6,275	7,217
2019	3.6900	8.924	32,753	33,254	5,687	7,707	8,148	11,961	6,807	12,703	7,399	6,791
2020	5.3000	10.479	33,266	45,635	7,882	4,388	13,795	11,749	13,368	10,876	6,942	10,788
2021	2.7300	12.680	45,804	56,234	4,616	11,258	6,947	23,380	12,561	17,572	11,299	12,103
2022	6.4800	13.764	56,197	58,271	11,542	13,102	26,445	26,127	18,886	19,694	12,349	13,427
2023	6.6500	11.131	58,054	54,049	11,836	4,820	26,584	28,740	18,814	21,663	15,260	14,769
2024	2.7300	10.900	54,318	55,903	4,863	19,325	18,096	27,732	17,425	20,358	13,145	13,192
2025	-	12.100	-	58,956	-	21,620	-	29,247	-	21,470	-	13,913
2026	-	2.F12X/td>	-	2.F12X/td>	-	2.F12X/td>	-	2.F121/td>	-	2.F121	-	2.F121
2027	-	1.F13X/td>	-	1.F13X/td>	-	1.F13X/td>	-	1.F131/td>	-	1.F131	-	1.F131
2028	-	0.F14X/td>	-	0.F14X/td>	-	0.F14X/td>	-	0.F141/td>	-	0.F141	-	0.F141